A comparison the 7th and 8th edition AJCCTNM staging systems for predicting disease free survival time after surgery in primary liver cancer patients
10.3760/cma.j.issn.1007-631X.2018.09.014
- VernacularTitle:第7版与第8版美国癌症联合会肝癌TNM分期对术后无瘤生存的预测比较
- Author:
Bin HE
1
;
Yinan SHEN
;
Tao MA
;
Chengxiang GUO
;
Tingbo LIANG
Author Information
1. 浙江大学医学院附属第二医院余杭分院普外科
- Keywords:
Carcinoma,hepatocellular;
Neoplasm staging;
Survival analysis
- From:
Chinese Journal of General Surgery
2018;33(9):760-763
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the value of the 7th and 8th edition AJCC TNM staging systems for hepatocellular cancer about disease free survival (DFS) after surgery.Methods Clinical data of hepatocellular cancinoma patients were analyzed retrospectively.The difference of the two staging systems in predicting DFS were compared by Kaplan-Meier analytical method and ROC test.Results Based on AJCC 7th edition,there were 114 phase Ⅰ patients,64 phase Ⅱ patients,18 phase Ⅲ patients,4 phase Ⅳ patients,while based on 8th edition,there were 33 phase ⅠA patients,85 Ⅰ B patients,60 phase Ⅱ patients,18 phase Ⅲ patients and 4 phase Ⅳ patients.There was a significant difference in the survival curve between the two stages (x2 =31.177,40.073,P ＜ 0.01).At the same time,the area under the ROC curve in the 8th edition was better than that in the 7th edition.In addition,in the 8th edition the DFS curve of phase ⅠA was superior to that of phase Ⅰ in 7th edition,and to that of phase ⅠB in the 8th edition (x2 =5.701,P =0.017;x2 =7.865,P =0.005).There was no significant difference between that of phase Ⅰ in the 7th edition and that of phase ⅠB in the 8th edition (~ =0.753,P =0.385).Conclusion The value of the 8th AJCC TNM staging in evaluating postoperative DFS is better than the 7th stage,especially for stage I patients.
